<p>SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th-22th October 2019.</p> <p>The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers&rsquo; safety. <br /> The event will explore how the latest technologies can benefit HPAPI with artificial intelligence and machine learning to hasten risk assessment and validation. We will also be dedication much deserved attention on emerging HPAPI therapies including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? Come and find the answers to these hot topics of HPAPI along with the other unique insights such as continuous HPAPI manufacturing technologies.</p> <p>Attend this conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry. <br /> &nbsp;</p>

<p>&bull;<strong> LISTEN </strong>for the most rational containment banding and how to apply solutions to mitigate the exposure risks<br /> &bull; <strong>Discovery</strong> the latest robotics and automated containment technologies to remove workers from risk exposure <br /> &bull; <strong>ASSESS</strong> the progress of oncology ADCs, is the industry reaching a dead-end for cure and are every HPAPI truly highly potent <br /> &bull; <strong>REVIEW</strong> the possibility of continuous manufacturing for HPAPI, how this approach can increase efficiency and other advantages<br /> &bull; <strong>UNDERSTAND</strong> the steps involved to evolve a containment environment to match that of the its scale of production and value of this practice<br /> &bull; <strong>HEAR</strong> about the implementation of artificial intelligence and machine learning to help gather and process data to hasten risk assessment<br /> &nbsp;</p>

<p>We Are One of A Kind...<br /> Networking: We keep networking at the forefront when it comes to our attendees. Expand your community with every part of the industry and with the right people to benefit your company and develop your career.<br /> The Agenda: Be sure to have your pen and pad ready at all times! A valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for our attendees.<br /> Location/Venue: Being held in Boston, a centre for scientific innovations, you will be surrounded by like-minded thinkers who are always aiming to go further than the frontier of science.<br /> Onsite: Our knowledgeable events team will provide you with an exceptional service onsite. They will answer any questions you may have and inform you about any changes to the agenda.<br /> &nbsp;</p>

<p>API specialists, Containment Engineers, Senior Scientists, Head of Scale-up Processings, Occupational Health Officers, Industrial Hygiene Leads, Head of Bioconjugations, Pharmaceutical Company Directors,Preclinical Safety Experts, Biopharmaceutical Developers, Industrial Hygienist, Industrial Hygienist Consultants, Occupational Toxicologists, Occupational Health Experts, Pharamaceutical Company Presidents and Vice Presidents, Head of Toxicology, Process Chemists, Process Research &amp; Develpoment, Head of Technology Transfer</p>

<p>AbbVie; Accord Healthcare; ACRAF S.P.A; ADC Biotechnology; ADC Biotechnology Ltd; Affygility Solutions; Antikor Biopharma; ARCINOVA; Astrazeneca&aacute;; Bayer Pharma; BSP Pharmaceuticals S.p.A.; CARBOGEN AMCIS AG; Cortex Consultancy; Cristalia Produtos Quimicos Farmaceuticos; Dec Group; Dishman Europe Limited; DSTL; Egis Pharmaceuticals PLC; Ferring Pharmaceuticals; Ferring Pharmaceuticals A/S; Gedeon Richter Plc.; Genentech; GlaxoSmithKline; Glythera; HPAPI Project Services Limited; Ipsen; Merck; Merck Group; Merck Serono GmbH; MINAKEM SAS; Nicomac Europe; Oncogen Pharma; Oril Industrie; Roche Pharma Research &amp; Early Development; SafeBridge Consultants, Inc; SafeBridge Europe Ltd; SK Biotek; Skyepharma S A; Swish Tech Limited; The University of Edinburgh;<br /> &nbsp;</p>

Sponsors and Exhibitors


To Be Confirmed

Boston, USA

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.

Sponsors and Exhibitors

SafeBridge Consultants, Inc.

Sponsors and Exhibitors

SafeBridge Consultants, Inc. is the premier resource for high level safety, health and environmental support to the pharmaceutical and biotechnology industries. We provide services in occupational and environmental toxicology, risk assessment, product safety, industrial hygiene and analytical chemistry to clients worldwide from offices in California, New York and Liverpool, UK.


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

To Be Confirmed


To Be Confirmed



speaker image






CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title


Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event


Sign up
Forgotten Password?


UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71

Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out